Biohaven .(BHVN) - 2023 Q3 - Quarterly Report

On October 5, 2023, we closed an underwritten public offering of 11,761,363 of its common shares, which included the exercise in full of the underwriters' option to purchase additional shares, at a price to the public of $22.00 per share. The net proceeds raised in the offering, after deducting underwriting discounts and expenses of the offering payable by us, were approximately $242.4 million. We intend to use the net proceeds received from the offering for general corporate purposes. We expect our expense ...